We recently showed that high fasting levels of growth hormone are associated with cardiovascular disease and that higher levels predict cardiovascular morbidity and mortality independently of traditional cardiovascular risk factors confirming previous reports from the 1990’s [2, 3]. Here, GH1 is linked to cardiovascular disorder.